StockData
Ocean Biomedical, Inc. logo

Ocean Biomedical, Inc. (OCEA) stock

OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)

Close on Oct 19, 2026Market cap $45.51KP/E –Yield –

Ocean Biomedical operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Ocean Biomedical's operating cash flow for the twelve months ending Mar 31, 2025 was -$4.05M. For fiscal 2024 it was -$4.18M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$4.18M–
FY2023Dec 31, 2023-$9.43M–
FY2022Dec 31, 2022-$993.00K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2025Mar 31, 2025-$356.00K–
Q4 FY2024Dec 31, 2024-$2.45M–
Q3 FY2024Sep 30, 2024-$957.00K–
Q2 FY2024Jun 30, 2024-$290.00K–
Q1 FY2024Mar 31, 2024-$485.00K–
Q4 FY2023Dec 31, 2023-$866.00K–
Q3 FY2023Sep 30, 2023-$1.13M–
Q2 FY2023Jun 30, 2023-$4.78M–
Q1 FY2023Mar 31, 2023-$2.65M–
Q4 FY2022Dec 31, 2022-$33.00K–
Q3 FY2022Sep 30, 2022-$442.00K–
Q2 FY2022Jun 30, 2022-$151.00K–
Q1 FY2022Mar 31, 2022-$367.00K–
Q3 FY2021Sep 30, 2021-$707.81K–

More Ocean Biomedical figures

See a number that looks wrong?